The CLL Sessions

CLL
8/3/20, 8:00 PM
Europe/Madrid GMT+2

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Frontline therapy for CLL, BTK inhibitors in CLL – ibrutinib/acalabrutinib, Novel combination therapy in CLL, MRD negativity in CLL and R/R CLL, Treatment sequencing & novel therapies

Inglês

 

Speakers

John Gribben, Susan O'Brien, Matthew Davids, Barbara Eichhorst

 

Link to the Event

Banner to the Event

The CLL Sessions